id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-0030-8455,FDA,FDA-2015-N-0030,"Memorandum of Understanding Addressing Certain Distributions of
Compounded Human Drug Products Between the State Board of Pharmacy or Other Appropriate State Agency and the Food and Drug Administration; Availability",Notice,Withdrawal,2020-10-27T04:00:00Z,2020,10,2020-10-27T04:00:00Z,,2020-10-27T13:41:21Z,2020-23687,0,0,090000648493647e
FDA-2015-N-0030-8454,FDA,FDA-2015-N-0030,Final Standard MOU Addressing Certain Distributions of Compounded Human Drug Products - For Implementation,Other,Additional Information,2020-10-26T04:00:00Z,2020,10,2020-10-26T04:00:00Z,,2020-10-26T12:19:15Z,,0,0,090000648492e60e